MYBPC3 and myocardial infarction: Cardiac myosin-binding protein C is a novel biomarker of myocardial injury with great potential for assisting in the early rule-out of AMI—other groups [64–66] have investigated the use of cMyC in the diagnosis of myocardial infarction with confirmatory findings [20, 22], but were limited by poor assay sensitivity.